As part of our cooperation with BDO Academy, we were invited to lecture on topics such as the role of the corporate secretariat, its importance to the organization, getting to know board directors, case law analysis, and corporate governance.

Our firm represented Trivago, a leading global hotel search platform, in its strategic investment and call option to acquire Holisto, an Israeli AI-driven travel tech platform that serves as a hotel rate aggregator and white-label booking engine provider. Adv. Ariella Dreyfuss and Adv. Dean Weinberg represented Trivago.

Our firm participated in the BDO Business Talk podcast, where we discussed payment services, the new regulatory requirements, and their impact on the financial industry.

Adv. Ariella Dreyfuss spoke as part of an IBA webinar on the key legal considerations of acquiring startups and early-stage companies in India.

Adv. Tal Freilich Hay spoke to participants of Tel Aviv University's "Yazamiyot - Female Entrepreneurs on Campus" program about core legal concepts in the world of entrepreneurship and startups.

Our firm represented a CFO who previously served at one of the largest construction companies in the country in a lawsuit filed with the Tel Aviv District Court (Economics Department). The lawsuit was initiated by the trustee appointed to the company as part of an insolvency proceeding. The CFO, who served for only a few months at the company, was one of dozens of defendants, including board members, members of management, controlling owners, and auditors, all of whom were held jointly and severally liable for damages allegedly amounting to approximately ILS 500 million due to the company’s collapse and subsequent insolvency proceedings. Despite the lawsuit raising several factual and legal claims against the CFO, we took the unusual step of filing a motion to dismiss the lawsuit outright on behalf of the CFO, before even submitting a statement of defense. The grounds for this motion included lack of cause and lack of standing. Following discussions with the trustee, an agreement was reached to remove the CFO from the lawsuit. As a result, the CFO was not held personally responsible for any of the alleged damages, with collective responsibility being attributed to all remaining defendants.

Our firm represents Mouro Capital, an investment fund that is a Vesttoo shareholder and has an appointed director, in the insolvency proceedings of Vesttoo, an international Israeli fintech company. The parallel proceedings are taking place in the United States and Israel, and Vesttoo's debts are estimated at approximately USD 3 billion. We represent Mouro Capital as Vesttoo and 48 affiliated entities undergo Chapter 11 proceedings in the United States. In Israel, debt restructuring enforcement proceedings and proceedings to recognize the foreign insolvency process are underway. As part of these matters, declaratory relief actions have been filed in Israel to establish jurisdiction over issues relating to the directors' activities at the company.

Adv. Gal Rozent, a competition law expert, was interviewed by TheMarker following news of Google's interest in acquiring the Israeli company Wiz. Gal explained current trends in the US and Europe and what competition authorities will request to examine to approve the deal.

Adv. Elad Reshtick, a partner at our firm, guest lectured to a corporate secretarial course at BDO Financial Academy. Elad addressed officer and director compensation, insider information and transactions involving interested parties, financial reporting for managers, and preparing for public offerings. Elad has been invited to lecture to the course again in August, where he will focus on board of director matters and corporate governance.

Our firm represented Thermo Fisher in its participation in CytoReason's USD 80 million financing round, alongside notable investors OurCrowd, Nvidia, and Pfizer. CytoReason provides pharmaceutical and therapeutic leaders with molecular-level insights and advanced AI tools that support data-driven decision-making in healthcare and the life sciences. Adv. Simon Jaffa, Adv. Ariella Dreyfuss, and Adv. Rahaf Awawdi represented Thermo Fisher in the transaction.